Pulse Biosciences (PLSE) Operating Income (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Operating Income of -$20.4 million for Q3 2025, down 49.15% year-over-year from -$40.1 million in Q3 2024, and little changed quarter-over-quarter from -$20.3 million in Q2 2025.
Pulse Biosciences (PLSE) Operating Income (2015 - 2026) Analysis & Trends
Pulse Biosciences' Operating Income history runs 11 years deep, the most recent figure standing at -$20.4 million for Q3 2025.
- In Q3 2025, Operating Income fell 49.15% year-over-year to -$20.4 million; the TTM figure through Sep 2025 stood at -$78.9 million (down 62.68% YoY), while the FY2024 annual figure was -$56.3 million, down 29.11% from the prior year.
- Operating Income for Q3 2025 stood at -$20.4 million, roughly flat from -$20.3 million in the prior quarter.
- The five-year high for Operating Income was -$8.7 million in Q4 2022, with the low at -$20.4 million in Q3 2025.
- The 5-year median for Operating Income is -$14.3 million (2021), against an average of -$14.7 million.
- The sharpest annual moves came in 2023 and 2025: Operating Income jumped 44.64% in 2023, then slumped 72.91% in 2025.
- Pulse Biosciences' Operating Income stood at -$15.4 million in 2021, then surged by 43.25% to -$8.7 million in 2022, then tumbled by 43.32% to -$12.5 million in 2023, then plunged by 61.66% to -$20.3 million in 2024, then fell by 0.52% to -$20.4 million in 2025.
- Business Quant data shows PLSE's Operating Income at -$20.4 million in Q3 2025, -$20.3 million in Q2 2025, and -$18.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 971.90 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 663.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 11.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 448.71 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 395.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 179.10 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 181.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -31.00 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 217.00 Mn |
| 10 | Pulse Biosciences | 3.33 Bn | 3.33 Bn | 161,000.00 | -25.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.27 Mn |
| Sep 30, 2025 | -20.37 Mn |
| Jun 30, 2025 | -20.28 Mn |
| Mar 31, 2025 | -18.04 Mn |
| Dec 31, 2024 | -20.26 Mn |
| Sep 30, 2024 | -13.66 Mn |
| Jun 30, 2024 | -11.73 Mn |
| Mar 31, 2024 | -10.62 Mn |
| Dec 31, 2023 | -12.53 Mn |
| Sep 30, 2023 | -11.25 Mn |
| Jun 30, 2023 | -10.23 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | -8.75 Mn |
| Sep 30, 2022 | -18.03 Mn |
| Jun 30, 2022 | -14.01 Mn |
| Mar 31, 2022 | -17.27 Mn |
| Dec 31, 2021 | -15.41 Mn |
| Sep 30, 2021 | -14.27 Mn |
| Jun 30, 2021 | -14.81 Mn |
| Mar 31, 2021 | -18.53 Mn |